These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 32266540)

  • 1. Natural history of most common spinocerebellar ataxia: a systematic review and meta-analysis.
    Diallo A; Jacobi H; Tezenas du Montcel S; Klockgether T
    J Neurol; 2021 Aug; 268(8):2749-2756. PubMed ID: 32266540
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term disease progression in spinocerebellar ataxia types 1, 2, 3, and 6: a longitudinal cohort study.
    Jacobi H; du Montcel ST; Bauer P; Giunti P; Cook A; Labrum R; Parkinson MH; Durr A; Brice A; Charles P; Marelli C; Mariotti C; Nanetti L; Panzeri M; Rakowicz M; Sulek A; Sobanska A; Schmitz-Hübsch T; Schöls L; Hengel H; Baliko L; Melegh B; Filla A; Antenora A; Infante J; Berciano J; van de Warrenburg BP; Timmann D; Szymanski S; Boesch S; Kang JS; Pandolfo M; Schulz JB; Molho S; Diallo A; Klockgether T
    Lancet Neurol; 2015 Nov; 14(11):1101-8. PubMed ID: 26377379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conversion of individuals at risk for spinocerebellar ataxia types 1, 2, 3, and 6 to manifest ataxia (RISCA): a longitudinal cohort study.
    Jacobi H; du Montcel ST; Romanzetti S; Harmuth F; Mariotti C; Nanetti L; Rakowicz M; Makowicz G; Durr A; Monin ML; Filla A; Roca A; Schöls L; Hengel H; Infante J; Kang JS; Timmann D; Casali C; Masciullo M; Baliko L; Melegh B; Nachbauer W; Bürk-Gergs K; Schulz JB; Riess O; Reetz K; Klockgether T
    Lancet Neurol; 2020 Sep; 19(9):738-747. PubMed ID: 32822634
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Survival in patients with spinocerebellar ataxia types 1, 2, 3, and 6 (EUROSCA): a longitudinal cohort study.
    Diallo A; Jacobi H; Cook A; Labrum R; Durr A; Brice A; Charles P; Marelli C; Mariotti C; Nanetti L; Panzeri M; Rakowicz M; Sobanska A; Sulek A; Schmitz-Hübsch T; Schöls L; Hengel H; Melegh B; Filla A; Antenora A; Infante J; Berciano J; van de Warrenburg BP; Timmann D; Boesch S; Pandolfo M; Schulz JB; Bauer P; Giunti P; Kang JS; Klockgether T; Tezenas du Montcel S
    Lancet Neurol; 2018 Apr; 17(4):327-334. PubMed ID: 29553382
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparable progression of spinocerebellar ataxias between Caucasians and Chinese.
    Lin YC; Lee YC; Hsu TY; Liao YC; Soong BW
    Parkinsonism Relat Disord; 2019 May; 62():156-162. PubMed ID: 30591349
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical characteristics of patients with spinocerebellar ataxias 1, 2, 3 and 6 in the US; a prospective observational study.
    Ashizawa T; Figueroa KP; Perlman SL; Gomez CM; Wilmot GR; Schmahmann JD; Ying SH; Zesiewicz TA; Paulson HL; Shakkottai VG; Bushara KO; Kuo SH; Geschwind MD; Xia G; Mazzoni P; Krischer JP; Cuthbertson D; Holbert AR; Ferguson JH; Pulst SM; Subramony SH
    Orphanet J Rare Dis; 2013 Nov; 8():177. PubMed ID: 24225362
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biological and clinical characteristics of individuals at risk for spinocerebellar ataxia types 1, 2, 3, and 6 in the longitudinal RISCA study: analysis of baseline data.
    Jacobi H; Reetz K; du Montcel ST; Bauer P; Mariotti C; Nanetti L; Rakowicz M; Sulek A; Durr A; Charles P; Filla A; Antenora A; Schöls L; Schicks J; Infante J; Kang JS; Timmann D; Di Fabio R; Masciullo M; Baliko L; Melegh B; Boesch S; Bürk K; Peltz A; Schulz JB; Dufaure-Garé I; Klockgether T
    Lancet Neurol; 2013 Jul; 12(7):650-8. PubMed ID: 23707147
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Frequency of SCA1, SCA2, SCA3/MJD, SCA6, SCA7, and DRPLA CAG trinucleotide repeat expansion in patients with hereditary spinocerebellar ataxia from Chinese kindreds.
    Tang B; Liu C; Shen L; Dai H; Pan Q; Jing L; Ouyang S; Xia J
    Arch Neurol; 2000 Apr; 57(4):540-4. PubMed ID: 10768629
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The natural history of spinocerebellar ataxia type 1, 2, 3, and 6: a 2-year follow-up study.
    Jacobi H; Bauer P; Giunti P; Labrum R; Sweeney MG; Charles P; Dürr A; Marelli C; Globas C; Linnemann C; Schöls L; Rakowicz M; Rola R; Zdzienicka E; Schmitz-Hübsch T; Fancellu R; Mariotti C; Tomasello C; Baliko L; Melegh B; Filla A; Rinaldi C; van de Warrenburg BP; Verstappen CC; Szymanski S; Berciano J; Infante J; Timmann D; Boesch S; Hering S; Depondt C; Pandolfo M; Kang JS; Ratzka S; Schulz J; Tezenas du Montcel S; Klockgether T
    Neurology; 2011 Sep; 77(11):1035-41. PubMed ID: 21832228
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spinocerebellar ataxia types 1, 2, 3, and 6: disease severity and nonataxia symptoms.
    Schmitz-Hübsch T; Coudert M; Bauer P; Giunti P; Globas C; Baliko L; Filla A; Mariotti C; Rakowicz M; Charles P; Ribai P; Szymanski S; Infante J; van de Warrenburg BP; Dürr A; Timmann D; Boesch S; Fancellu R; Rola R; Depondt C; Schöls L; Zdienicka E; Kang JS; Döhlinger S; Kremer B; Stephenson DA; Melegh B; Pandolfo M; di Donato S; du Montcel ST; Klockgether T
    Neurology; 2008 Sep; 71(13):982-9. PubMed ID: 18685131
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term evolution of patient-reported outcome measures in spinocerebellar ataxias.
    Jacobi H; du Montcel ST; Bauer P; Giunti P; Cook A; Labrum R; Parkinson MH; Durr A; Brice A; Charles P; Marelli C; Mariotti C; Nanetti L; Sarro L; Rakowicz M; Sulek A; Sobanska A; Schmitz-Hübsch T; Schöls L; Hengel H; Baliko L; Melegh B; Filla A; Antenora A; Infante J; Berciano J; van de Warrenburg BP; Timmann D; Szymanski S; Boesch S; Nachbauer W; Kang JS; Pandolfo M; Schulz JB; Melac AT; Diallo A; Klockgether T
    J Neurol; 2018 Sep; 265(9):2040-2051. PubMed ID: 29959555
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dystonia and ataxia progression in spinocerebellar ataxias.
    Kuo PH; Gan SR; Wang J; Lo RY; Figueroa KP; Tomishon D; Pulst SM; Perlman S; Wilmot G; Gomez CM; Schmahmann JD; Paulson H; Shakkottai VG; Ying SH; Zesiewicz T; Bushara K; Geschwind MD; Xia G; Subramony SH; Ashizawa T; Kuo SH
    Parkinsonism Relat Disord; 2017 Dec; 45():75-80. PubMed ID: 29089256
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Postural Tremor and Ataxia Progression in Spinocerebellar Ataxias.
    Gan SR; Wang J; Figueroa KP; Pulst SM; Tomishon D; Lee D; Perlman S; Wilmot G; Gomez CM; Schmahmann J; Paulson H; Shakkottai VG; Ying SH; Zesiewicz T; Bushara K; Geschwind MD; Xia G; Subramony SH; Ashizawa T; Kuo SH
    Tremor Other Hyperkinet Mov (N Y); 2017; 7():492. PubMed ID: 29057148
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disease progression of spinocerebellar ataxia types 1, 2, 3 and 6 before and after ataxia onset.
    Jacobi H; Schaprian T; Schmitz-Hübsch T; Schmid M; Klockgether T;
    Ann Clin Transl Neurol; 2023 Oct; 10(10):1833-1843. PubMed ID: 37592453
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SARA captures disparate progression and responsiveness in spinocerebellar ataxias.
    Petit E; Schmitz-Hübsch T; Coarelli G; Jacobi H; Heinzmann A; Figueroa KP; Perlman SL; Gomez CM; Wilmot GR; Schmahmann JD; Ying SH; Zesiewicz TA; Paulson HL; Shakkottai VG; Bushara KO; Kuo SH; Geschwind MD; Xia G; Pulst SM; Subramony SH; Ewenczyk C; Brice A; Durr A; Klockgether T; Ashizawa T; Tezenas du Montcel S
    J Neurol; 2024 Jul; 271(7):3743-3753. PubMed ID: 38822840
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Natural history and epidemiology of the spinocerebellar ataxias: Insights from the first description to nowadays.
    Scott SSO; Pedroso JL; Barsottini OGP; França-Junior MC; Braga-Neto P
    J Neurol Sci; 2020 Oct; 417():117082. PubMed ID: 32791425
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genotype-specific spinal cord damage in spinocerebellar ataxias: an ENIGMA-Ataxia study.
    Rezende TJR; Adanyaguh I; Barsottini OGP; Bender B; Cendes F; Coutinho L; Deistung A; Dogan I; Durr A; Fernandez-Ruiz J; Göricke SL; Grisoli M; Hernandez-Castillo CR; Lenglet C; Mariotti C; Martinez ARM; Massuyama BK; Mochel F; Nanetti L; Nigri A; Ono SE; Öz G; Pedroso JL; Reetz K; Synofzik M; Teive H; Thomopoulos SI; Thompson PM; Timmann D; van de Warrenburg BPC; van Gaalen J; França MC; Harding IH
    J Neurol Neurosurg Psychiatry; 2024 Jun; 95(7):682-690. PubMed ID: 38383154
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Frequency of spinocerebellar ataxia types 1, 2, 3, 6, and 7 in Australian patients with spinocerebellar ataxia.
    Storey E; du Sart D; Shaw JH; Lorentzos P; Kelly L; McKinley Gardner RJ; Forrest SM; Biros I; Nicholson GA
    Am J Med Genet; 2000 Dec; 95(4):351-7. PubMed ID: 11186889
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peripheral Neuropathy in Spinocerebellar Ataxia Type 1, 2, 3, and 6.
    Linnemann C; Tezenas du Montcel S; Rakowicz M; Schmitz-Hübsch T; Szymanski S; Berciano J; van de Warrenburg BP; Pedersen K; Depondt C; Rola R; Klockgether T; García A; Mutlu G; Schöls L
    Cerebellum; 2016 Apr; 15(2):165-73. PubMed ID: 26054379
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between proton magnetic resonance spectroscopy measurements and CAG repeat number in patients with spinocerebellar ataxias 2, 3, or 6.
    Wang PS; Chen HC; Wu HM; Lirng JF; Wu YT; Soong BW
    PLoS One; 2012; 7(10):e47479. PubMed ID: 23094053
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.